Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02601313
Title A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications

mantle cell lymphoma

Therapies

axicabtagene ciloleucel + Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA | FRA | DEU


No variant requirements are available.